| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/24/2009 | US7507792 MDA-7 proteins and methods of use thereof |
| 03/24/2009 | US7507789 Detection of Anaplasma platys |
| 03/24/2009 | US7507787 Polynucleotides; induce immunology response; antiinflammatory agents; detection polynucleotide patten |
| 03/24/2009 | US7507751 Biphenyl derivatives |
| 03/24/2009 | US7507711 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507675 Silicon substrate is irradiated to produce silicon oxide; reacted with 1-alkene or alkylne; Field Effect Transistor (FET) structures, gate of FET being formed by functionalized organic monolayer containing oligosaccharides or oligopeptides, capable of interacting with biological substance; biosesors |
| 03/24/2009 | US7507588 Multiplex microparticle system |
| 03/24/2009 | US7507585 Methods and systems for indentifying and monitoring S-nitrosothiols in biological samples |
| 03/24/2009 | US7507584 via determination of the levels of stress markers interleukin 8 (IL8), monocyte chemotactic protein-1 (MCP1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and thyroid stimulating hormone (TSH) |
| 03/24/2009 | US7507583 Leaching soil with acid; fusing with base; cerium fluoride precipitation for removing the soil matrix and precipitates plutonium, americium, and curium with cerium and hydrofluoric acid followed by separating these actinides using chromatography cartridges; oxidizing uranium to prevent uranium oxidation |
| 03/24/2009 | US7507576 Method of manufacturing probe carrier |
| 03/24/2009 | US7507565 Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507555 polypeptides linked to chromogens capable of fluorescence resonance energy transfer, used for the quantitative analysis of molecules that relay signals received at receptors on a cell surface to target molecules in the cytosol and/or nucleus |
| 03/24/2009 | US7507553 Galleria mellonella derived composition for detecting peptidoglycan, a method for use thereof, and a diagnostic kit containing the same |
| 03/24/2009 | US7507552 Crystallization of histone deacetylase 2 |
| 03/24/2009 | US7507551 Multiple quantification method for cholesterol in low-density lipoproteins |
| 03/24/2009 | US7507550 Analytical sandwich test for determining NT-proBNP |
| 03/24/2009 | US7507549 Method for following the progress of prostate cancer |
| 03/24/2009 | US7507548 Multidimensional detection of aberrant phenotypes in neoplastic cells to be used to monitor minimal disease levels using flow cytometry measurements |
| 03/24/2009 | US7507547 contacting test compounds with cells expressing neurotensin receptors on its cell surface and with neurotensin receptor ligand, then monitoring binding of the ligand to the cells and selecting the test compound if they enhance binding of the ligands to the cells; drug screening |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/24/2009 | US7507545 Ion channel modulating activity method |
| 03/24/2009 | US7507544 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 03/24/2009 | US7507543 GABAB receptor polypeptides and screening methods |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507538 Human papilloma virus immunoreactive peptides |
| 03/24/2009 | US7507537 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/24/2009 | US7507532 diagnosis of cancer in patients, by determining the level of oncogene expression in blood and detecting mRNA encoded by polynucleotide in peripheral blood mononuclear cells; screening for moderators and gene expression inhibitors, used for treating cancers in vivo |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507528 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells |
| 03/24/2009 | US7507469 Substrate comprises sintered porous polymer material; first layer comprises molecules bound to substrate surface through covalent bounds or electrostatic interactions; second layer comprises molecules bound to first layer through covalent bounds or electrostatic interactions; for extraction, separation |
| 03/24/2009 | US7507418 Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes |
| 03/24/2009 | US7507408 Anti hepatitis C virus antibody and uses thereof |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | US7507395 Include pH-sensitive fluorescent and fluorogenic 2',7'-dialkylfluorescein derivatives and associated nonfluorescent precursor compounds; malignancy, multidrug resistance, lysosome storage disease, corneal acidosis, ulcer disease, diabetic heart condition, or hyperglycemia |
| 03/24/2009 | US7507377 Device for automatic analysis of a liquid sample |
| 03/24/2009 | US7507375 An arm arranged to influence a test electrode to a relative movement relative to magazine; quantitative and qualitative analysis of blood sugar, protein in urine etc. |
| 03/24/2009 | US7507373 Assay device for the testing of fluid samples |
| 03/24/2009 | US7506808 Shopping receptacle with in-built scanner |
| 03/24/2009 | CA2481193C Improved electrochemical biosensor test strip |
| 03/24/2009 | CA2466877C Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/24/2009 | CA2422089C Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains |
| 03/24/2009 | CA2407715C Diagnostics and therapeutics for macular degeneration-related disorders |
| 03/24/2009 | CA2404262C Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| 03/24/2009 | CA2383764C Method for modelling fluid displacement in a porous environment taking into account hysteresis effects |
| 03/24/2009 | CA2376500C Allergen detection |
| 03/24/2009 | CA2370174C Status detection apparatus and method for fluid-filled electrical equipment |
| 03/24/2009 | CA2356442C Nmr spectroscopic in vitro assay using hyperpolarization |
| 03/24/2009 | CA2354635C Sequencing method using magnifying tags |
| 03/24/2009 | CA2283154C Method and apparatus for measurement of blood substitutes |
| 03/24/2009 | CA2260991C Multiplex flow immunoassays with magnetic particles as solid phase |
| 03/23/2009 | CA2701047A1 Antibody against anthrax toxins |
| 03/21/2009 | CA2603615A1 Methods of reducing viral infection and kits therefore |
| 03/19/2009 | WO2009036447A1 Salivary bioassay for early detection of bone loss |
| 03/19/2009 | WO2009036429A2 Improved quality assurance system and method for point-of-care testing |
| 03/19/2009 | WO2009036414A1 Method of selectively inhibiting pkciota |
| 03/19/2009 | WO2009036376A1 Fatty acid markers for the diagnosis, prognosis and management of cardiovascular disease |
| 03/19/2009 | WO2009036336A2 Biomarkers for motor neuron disease |
| 03/19/2009 | WO2009036288A1 Multiple analyte diagnostic readout |
| 03/19/2009 | WO2009036283A2 Differential diagnosis of b-cell chronic lymphocytic leukemia |
| 03/19/2009 | WO2009036241A1 Live attenuated mycoplasma strains |
| 03/19/2009 | WO2009036236A1 Mirna expression in human peripheral blood microvesicles and uses thereof |
| 03/19/2009 | WO2009036227A1 Detecting hepatitis b virus |
| 03/19/2009 | WO2009036168A2 Devices and methods for the collection and detection of substances |
| 03/19/2009 | WO2009036123A1 Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| 03/19/2009 | WO2009036120A1 Cellular antioxidant activity (caa) assay |
| 03/19/2009 | WO2009036063A1 Pseudotyped retroviral vectors and methods of making and using them |
| 03/19/2009 | WO2009036036A1 Methods and compositions based on culturing microorganisms in low sedimental fluid shear conditions |
| 03/19/2009 | WO2009036011A2 Markers for ventricular arrhythmia |
| 03/19/2009 | WO2009036010A1 Bacterial vaginosis apparatus and diagnostic methods |
| 03/19/2009 | WO2009035946A1 Distinguishing between invasive ductal carcinoma and invasive lobular carcinoma using raman molecular imaging |
| 03/19/2009 | WO2009035942A1 Distinguishing between renal oncocytoma and chromophobe renal cell carcinoma using raman molecular imaging |
| 03/19/2009 | WO2009035929A2 Cardiovascular and brain cell therapy using intracellular ryanodine receptor modulation by the estrogen receptor beta |
| 03/19/2009 | WO2009035847A1 Apparatus and methods for encapsulation of in vitro diagnostic reagents |
| 03/19/2009 | WO2009035732A2 Detection and quantification of biomarkers via a piezoelectric cantilever sensor |
| 03/19/2009 | WO2009035631A1 Determining disease or immune system features based on analysis of immune system characteristics |
| 03/19/2009 | WO2009035554A2 Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem |
| 03/19/2009 | WO2009035529A1 Method of analysis, detection and correction of food intolerance in humans |
| 03/19/2009 | WO2009035476A1 Resonance energy transfer assay with cleavage sequence and spacer |
| 03/19/2009 | WO2009035420A1 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 03/19/2009 | WO2009035412A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 03/19/2009 | WO2009035402A1 Diagnosis of cancer by determining polymorphisms in blm, top3a or rmil |
| 03/19/2009 | WO2009035357A2 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 03/19/2009 | WO2009035347A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/19/2009 | WO2009035125A1 Cantilever-type sensor, as well as a substance sensing system and a substance sensing method that use the sensor |
| 03/19/2009 | WO2009035008A1 Method of measuring chemiluminescence and chemiluminescence measuring apparatus |
| 03/19/2009 | WO2009034961A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent |
| 03/19/2009 | WO2009034958A1 Protein stabilizer, method for producing the same, method for using protein stabilizer, and method for stabilizing protein |
| 03/19/2009 | WO2009034951A1 Method for quantification of steroid hormone |
| 03/19/2009 | WO2009034842A1 Nucleic acid detection method, and nucleic acid detection kit |
| 03/19/2009 | WO2009034790A1 Fluorescent molecule |
| 03/19/2009 | WO2009034779A1 Cancer diagnosis kit and cancer diagnosis method |
| 03/19/2009 | WO2009034563A2 An analysis system |
| 03/19/2009 | WO2009034562A2 A method of assessing lung squamous cell carcinoma status in an individual |
| 03/19/2009 | WO2009034470A2 Future cardiac event biomarkers |